Following feedback from the U.S. Food and Drug Administration (FDA), Larimar Therapeutics is on track to soon submit an application seeking accelerated approval — which gets a drug to patients but still requires additional testing — of nomlabofusp, its protein replacement therapy for Friedreich’s ataxia (FA). Larimar recently…

I’ve heard the term “wheelchair-bound” in the media a lot lately. I hate those words. I use a wheelchair because of the symptoms of the disease I have, Friedreich’s ataxia (FA). These symptoms — muscle weakness and neurological problems — mean that at this point in my FA…

Friedreich’s ataxia (FA) affects my abilities, mood, energy levels, major musculoskeletal functions, and choices. It determines my days in ways far beyond what a 23-year-old newly diagnosed me could imagine. It is a lot to process. But, like most things, I get kind of “used to” it. New adaptations can…

Abnormal buildup of iron in mitochondria, the powerhouses of cells, may contribute to heart damage in Friedreich’s ataxia, according to a new study done in a mouse model. Data also indicate that heart cells have reduced ability to recycle damaged mitochondria in Friedreich’s ataxia. Collectively, the findings shed new…

Nobody likes getting sick. I’ve been battling a stubborn flu virus for a few weeks now. It’s likely the same one my husband, Dave, had for just four days. Not fair, I joke with Dave. Not only am I dealing with this bug for much longer than he did, but…